Renal PK Study of LC350189

Status:
Completed

Trial end date:
2020-09-12

Target enrollment:

Participant gender:

This is a Phase 1, open-label, parallel-group, multiple-dose study designed to assess the effect of renal impairment on the PK and PD of LC350189.

Phase 1

LG Chem